Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?

Guidelines published in 2021 have supported natriuretic peptide (NP) testing for the prognostication in patients with acute coronary syndrome (ACS) and for the diagnosis of chronic and acute heart failure (HF). Our objective was to determine if the addition of N-terminal pro B-type NP (NT-proBNP) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavsak, Peter A., Mondoux, Shawn E., Hewitt, Mark K., Ainsworth, Craig, Hill, Stephen, Worster, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471149/
https://www.ncbi.nlm.nih.gov/pubmed/34564124
http://dx.doi.org/10.3390/jcdd8090106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471149/
https://www.ncbi.nlm.nih.gov/pubmed/34564124
http://dx.doi.org/10.3390/jcdd8090106

Ejemplares similares